Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Controlled Trial of Olanzapine Versus Active Comparator in the Treatment of Schizophrenic and Schizoaffective Subjects With Comorbid Depression

NCT00034801 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00034801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00034801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Controlled Trial of Olanzapine Versus Active Comparator in the Treatment of Schizophrenic and Schizoaffective Subjects With Comorbid Depression
Lead sponsor
Eli Lilly and Company
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2001
Completion date
March 31, 2003
Enrollment
378
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

depression, schizoaffective disorder, schizophrenia